Skip to main content
Frontiers in Nutrition logoLink to Frontiers in Nutrition
. 2025 Jul 9;12:1604819. doi: 10.3389/fnut.2025.1604819

Vitamin D status among apparently healthy individuals in the UAE: a systematic review

Maitha Abdulla Alshamsi 1, Wafeeqa Fatima 1, Maitha Tareq Al Teneiji 1, Suresh Kumar Srinivasamurthy 1,2,*
PMCID: PMC12284947  PMID: 40704317

Abstract

Background/objectives

Vitamin D deficiency is a global health concern, particularly in regions with abundant sunlight, such as the UAE. This study aims to systematically review and meta-analyze available data on vitamin D levels in apparently healthy individuals in the UAE, categorizing findings by demographic factors, including age, gender, and ethnicity. The goal is to assess the extent of deficiency and identify potential contributing factors.

Methods

A systematic review was conducted following PRISMA guidelines. PubMed and SCOPUS databases were searched for studies reporting serum vitamin D levels in healthy individuals in the UAE. Eligible studies included cross-sectional, retrospective, prospective, and comparative designs. Data were extracted and analyzed, with vitamin D levels categorized as deficient, insufficient, or normal. Study quality was assessed using a modified Newcastle–Ottawa scale for single-arm studies.

Results

A total of 35 studies involving 28,260 participants were included. Reported vitamin D levels ranged from 5.2 ± 2.8 ng/mL to 42.5 ± 19.5 ng/mL. The pooled mean (SD) for adults above 18 years was 17.63 ng/mL (95% CI: 14.28 to 20.99) indicating widespread deficiency. Among participants, 65% were female, 34% were male, and 1% were infants. Severe deficiency was noted in infants and children, though limited studies focused on these groups.

Conclusion

Despite high sunlight exposure, vitamin D deficiency is prevalent in the UAE, likely due to cultural clothing practices, limited outdoor activities, darker skin pigmentation, and dietary insufficiencies. Further research on vulnerable populations is needed. Variations in assay methods used across studies (e.g., RIA, ECLIA, LC–MS/MS) may have influenced reported vitamin D levels and contributed to heterogeneity in findings.

Systematic review registration

https://www.crd.york.ac.uk/PROSPERO/view/CRD42024587972, Identifier, CRD42024587972.

Keywords: systematic review, vitamin D levels, in UAE, vitamin D deficiency, healthy population

Introduction

Vitamin D deficiency is a widespread global issue in developed and developing countries, affecting approximately 1 billion people, with an additional 50% of the global population experiencing insufficiency (1). As a fat-soluble vitamin, it plays a crucial role in maintaining bone health, supporting immune function, and promoting overall well-being (2). Vitamin D, beyond its traditional role in bone health, acts as a secosteroid hormone regulating over 200 genes involved in immunity, inflammation, and cell function. Its deficiency is now associated with various conditions, including autoimmune, cardiovascular, metabolic, and neurodegenerative diseases, as well as certain cancers. The evidence also highlighted vitamin D role in mechanisms like NF-κB suppression, mitochondrial regulation, and gut microbiome modulation (3). Recent study suggests vitamin D supplements can reduce cancer-related mortality by 15% (4).

Vitamin D is synthesized in the skin when exposed to sunlight, specifically ultraviolet B (UVB) rays. When UVB light hits the skin, it converts a compound called 7-dehydrocholesterol, found in the skin, into vitamin D3 (cholecalciferol). This form of vitamin D is then transported to the liver, where it is converted into a substance called 25-hydroxyvitamin D (calcidiol). Finally, it travels to the kidneys, where it is converted into the active form of vitamin D, called calcitriol. This active form helps the body absorb calcium and phosphate, which are important for bone health and other bodily functions (5).

The prevalence of hypovitaminosis D (25(OH)D < 20 ng/mL) in the Middle East and North Africa varies across populations, ranging between 12 and 96% in children and adolescents, 54–90% in pregnant women, and 44–96% in adults (6). A study conducted in Abu Dhabi with 12,346 participants found that 72% of participants were vitamin D deficient (<20 ng/mL) and 10% were insufficient (20–30 ng/mL). This study also showed the high prevalence of vitamin D deficiency is consistent across both sexes, with 83.1% of males and 83.8% of females being deficient (7).

Despite the abundance of sunshine in the UAE, with an average of 10 h of sunlight per day, vitamin D deficiency remains prevalent. The severity of the situation is further highlighted by a large-scale study involving 7,924 patients in Dubai, which reported an overall mean serum 25(OH)D level of approximately 20 ng/mL, with 85.4% of the population being vitamin D deficient (8).

Though many studies have reported vitamin D levels from the UAE, there is a need for a systematic review of all these research studies to collate and analyze data on reported vitamin D levels. Hence this study was planned to report vitamin D levels in the apparently healthy population in the UAE as measured by liquid chromatography such as LC–MS–MS or by immunoassays, to find out the age group in which vitamin D deficiency is the most prevalent, and to identify the extent of vitamin D deficiency in various demographic groups within the UAE. The review also explores to evaluate methodological variations among included studies.

This review aims to support policymakers in the UAE by providing evidence-based insights into the burden and distribution of vitamin D deficiency, thereby informing public health interventions, screening programs, and national guidelines.

Methodology

The study protocol was registered with Prospero (CRD42024587972). This systematic review complied with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for reporting (9).

Literature search

We searched PubMed and SCOPUS databases using the following search terms [(“vitamin d” OR cholecalciferol OR 1,25-dihydroxycholecalciferol) AND (uae OR “united arab emirates”)] for original articles on vitamin D serum levels in the apparently healthy UAE population (locals and non-locals) published from inception till July 1st, 2024.

We manually screened for the articles without using any software. We divided the procedure into 4 steps. In step 1, we screened using search terms. A total of 369 records were generated (324 articles from PubMed and 45 articles from SCOPUS), out of which 18 were excluded due to duplication, giving us 351 articles. Duplicate studies were identified by cross-checking article titles. In step 2 - we screened by the title and abstract, out of which 303 were excluded (276 articles from PubMed and 27 articles from SCOPUS) and 48 included (from PubMed only). In step 3 - we screened the 48 articles by full text, out of which 6 articles had repeated datasets and 9 articles did not fit our criteria. Hence these 15 articles were excluded, and the remaining 33 included. In step 4 - we screened the references of the included articles and found additional 2 articles, which fit our criteria. Hence a total number of 35 articles were included in this systematic review (Figure 1).

Figure 1.

Flowchart illustrating the process of study identification via databases and registers. Initially, 369 records are identified from PubMed (324) and Scopus (45), with 18 duplicates removed. After screening 351 records, 303 are excluded. Sixteen reports are sought for retrieval, with 48 assessed for eligibility. Thirteen reports are excluded, including six repeated datasets and nine not meeting inclusion criteria. Finally, 35 studies are included in the review, comprising 33 from full-text screening and two from reference screening.

PRISMA flowchart describing the selection of studies for the systematic review. *We searched two electronic databases The number of records identified from each database is reported separately. **No automation tools were used for screening or exclusion; all records were assessed manually by reviewers.

Study selection

Studies were included in the present review if they met the following criteria: (1) outcome: articles reporting Vitamin D levels in the apparently healthy population (control population); (2) timeline: all articles published from the inception till July 1, 2024; (3) study participants: studies including all age groups and multiple ethnicities in the UAE (including locals and residents). (4) study designs: cross-sectional, retrospective, prospective, and comparative studies.

All studies conducted exclusively on patients with specific conditions, such as diabetes, hypertension, obesity, prematurity, infertility, and others, were excluded, Along with studies done on patients taking vitamin D supplements. Additionally, case reports, conference papers, in vitro studies, animal studies, and articles written in languages other than English were excluded.

Data extraction

We organized the data from the included 35 articles into a master table made in an Excel sheet. All studies were independently screened and evaluated for selection by 3 authors (WF, MT, MA) initially. Once the data was collected it was cross-checked twice by the authors (WF, MT, MA). And it was finally reviewed for the third time by one of the authors (SK). Each study was evaluated using a data extraction form. For each study, we assessed a wide range of variables including Author Name, Year of Publication, Study designs, Number of arms (groups), Definition of controls, Study population age range, Mean age, Gender and ethnicity, Sample size, Sample per arm, Methods of assay of vitamin D, Quality assurance of lab methods, Sample (venous blood and saliva), Reported season, Reference level, Reported value, Converted value (to ng/mL), Standard deviation (SD), Percentages of vitamin D deficiency (VD-D), Insufficiency (VD-I), and Normal (VD-N), Reported values in subgroups, Converted values in subgroup (to ng/mL), Conclusion, Additional data, Ethics committee, Informed consent, Sample size calculations, and Statistics.

The quality analysis was done using the modified Newcastle–Ottawa scale for single-arm studies (10). The scoring was based on five specific parameters: definition of control, reported vitamin D, quality assurance of laboratory methods used for vitamin D measurement, ethics committee approval, and sample size calculation. Each study was scored based on these five parameters, with 1 point assigned for each criterion met, resulting in a total score out of 5.

Articles were systematically categorized into three demographic groups: mothers and infants, under 18 years of age, and above 18 years of age. The random-effects model was used for meta-analysis for the studies reporting subjects above 18 years category using R package version 4.4.2. Below 18 years and mothers and infants were not included in the meta-analysis due to sparsity in the number of studies. The conversion of data with respect to units and from interquartile ranges was done from a metaanalysis accelerator (11).

Results

The studies included in the systematic review consisted of 35 studies involving 28,260 subjects. The studies reporting among subjects above 18 years (n = 26,129; Table 1), 1–18 years (n = 1,073; Table 2), and mothers with infants (n = 1,058; Table 3) were segregated and reported separately.

Table 1.

Summary of studies reporting vitamin D levels in adults aged 18 years and above.

Author name Study design Number of arms (groups) Study population age range Study population age (yr.) mean (SD) Study population gender Study population ethnicity Sample size Sample per arm Reported value Converted value (ng/mL) mean (SD)
Dawodu et al. (26) Pilot Study 3 (Emirati, Non-Gulf Arabs, and Europeans) 19–44 years Emirati: 23.6 (18·5–28·7); Non-Gulf Arabs: 25·8 (19·6–32·0); Europeans: 32·7 (28·5–36·9) Females Emirati, non-Gulf Arabs, and Europeans N = 75 Emirati (n = 33); Non-Gulf Arabs (n = 25); European (n = 17) Not mentioned Not applicable
Saadi et al. (32) Not mentioned 2 (Premenopausal and Postmenopausal) 20–75 years Median (range): 39 (20–72) Females Emirati N = 56 Premenopausal (n = 38); postmenopausal (n = 18) Premenopausal = 25OHD * ≥ 30 nmol/L: 39.3 ± 8.0 nmol/L; * < 30 nmol/L: 21.1 ± 5.2 nmol/L
Postmenopausal: not mentioned
Premenopausal = 25OHD* ≥ 12 ng/mL: 15.7 ± 3.2 ng/mL; * < 12 ng/mL: 8.5 ± 2.1 ng/mL
Postmenopausal: not mentioned
Saadi et al. (33) Not mentioned 2 (Premenopausal and Postmenopausal) 20–85 years Premenopausal: 37.5 ± 9.5; Postmenopausal: 58.3 ± 8.9 Females Emirati N = 259 Premenopausal women (n = 175); Postmenopausal (n = 84) 25.3 ± 10.8 nmoL/L 10.1 (4.3) ng/mL
Dawodu et al. (27) Pilot study 1 20–30 years Median (range): 24 (23–28) Females Arabs N = 8 Nil Median (range) = 17.6 (3.8–23.8) nmol/L 6.3 (2.78) ng/mL
Al Anouti et al. (17) Cross sectional study 1 Not mentioned Males: 21.0 ± 4.6; Females: 20.8 ± 4.0 Females (n = 208); Males (n = 70) Emirati N = 278 Nil 23.1 ± 15.5 nmol/L 9.3 (6.2) ng/mL
Al-Anouti et al. (20) Not mentioned 1 Not mentioned Median 43 (35–49) Males (88%); Females (12%) Emirati, Non-Gulf Arabs, Europeans, Canadians, and South Asians N = 141 Nil Median 22 (17 to 31) nmol/L 9.33 (4.19) ng/mL
Yammine et al. (8) Cross-sectional retrospective study 1 Not mentioned Mean age 37 Males (n = 2,418); Females (n = 5,506) Locals and Non-locals N = 7,924 Nil 19.9 (11.3) ng/mL Conversion not needed
Anouti et al. (24) Not mentioned 2 (VTD sufficient and VTD insufficient) Not mentioned VTD insufficient: 19.72 ± 0.19; VTD sufficient: 20.15 ± 0.55 Males (n = 52); Females (n = 111) Emirati N = 163 VTD insufficient (n = 136); VTD sufficient (n = 27) 13.52 ± 6.86 ng/mL Conversion not needed
Bani-Issa et al. (25) Cross-sectional study 1 18–64 years Not mentioned Females (n = 136); Males (n = 80) Emirati and non-Emirati N = 216 Nil Not mentioned Not applicable
Inman et al. (30) Pilot study 1 ≥ 18 years 29.08 ± 8.45 Males (n = 200); Females (n = 104) Emirati N = 331 Nil 21.36 (10.28) ng/mL Conversion not needed
Hasan et al. (29) Cross-sectional study 1 Not mentioned Median age 21 (9) years Males (n = 50); Females (n = 148) Arab N = 198 Nil 25.5 (18.2) (nmol/L) 10.2 (7.28)ng/mL
Thomas et al. (36) Convenience sample 1 Not mentioned 20.83 (3.98) years Females Emirati N = 114 Nil 23.66 (SD = 12.31) nmol/L 9.5 (4.9)ng/mL
Nimri et al. (31) Cross-sectional study 1 18–26 years 20.19 (1.82) Females Not mentioned N = 480 Nil 21.67 ± 9.5 ng/mL Conversion not needed
Abdulle et al. (16) Case–control study 2 (T2D and controls) ≥ 18 years Controls - 50.7 ± 15.4 Control-Females (72.6%); Males (27.4%) Emirati N = 431 Control (n = 215); T2D Cases (n = 216) Controls—29.3 ± 13.4 ng/ml Conversion not needed
Al Zarooni et al. (7) Cross-sectional retrospective observational study 1 18–106 years Mean of 38.5 years Male (n = 4,561); Female (n = 7,785) Emirati N = 12,346 Nil Not mentioned Not applicable
Sharif-Askari et al. (35) Not mentioned 2 (insulin sensitive and insulin resistant) 18 to 80 years Insulin sensitive- 38 (12) Insulin sensitive- Males (n = 862); Females (n = 357) Arabs, Asian, others N = 4,114 Insulin sensitive (n = 1,354); insulin resistant (n = 2,760) Median (IQR) of Insulin sensitive: 31.20 (21.4) ng/mL Conversion not needed
Al-Amad et al. (19) Case–control study 1 > 18 years Mean of 31 years Males (n = 32); Females (n = 20) Not mentioned N = 52 Nil 51.5 (26.9) nmol/l 20.6 (10.8) ng/mL
Saeed et al. (34) Cross-sectional and prospective 1 18–26 years 19.9 ± 1.6 Males (n = 98); Females (n = 189) Emirati, Arab non-Emirati, and Non-Arab N = 287 Nil 15.8 (19.5 ± 11.6) ng/ml Conversion not needed
Gariballa et al. (28) Randomized controlled trial 1 ≥ 18 years 41 ± 12 Males (n = 73); Females (n = 204) Emirati and Arab N = 277 Nil 23.7 (11)ng/ml Conversion not needed
Al Zarooni et al. (18) Cross-sectional retrospective observational study 1 18–70 years 38.9 (13.2) years Females (61.5%); Males (38%) Emirati N = 392 Nil Mean vitamin D levels of physically active: (38.2 nmol/L), Physically inactive: (31.7 nmol/L).
Depending on the nature of work: sedentary work (29.6 nmol/L), physically demanding work (37.1 nmol/L).
Mean vitamin D levels of physically active: (15.3 ng/mL), Physically inactive: (12.7 ng/mL).
Depending on the nature of work: sedentary work (11.9 ng/mL), physically demanding work (14.9 ng/mL).
Anouti et al. (23) Cross-sectional study 1 ≥ 18 years 35 (10) Females Philippines, Arab, and South Asian N = 553 *there is discrepancy Nil 20 ± 11 ng/mL Conversion not needed
AlAnouti et al. (21) Not mentioned 1 ≥ 18 years Median (IQR) = 30 (23, 38) Males (n = 281); Females (n = 118) Emirati N = 399 Nil Median (IQR) = 19.5 (15.5, 25.6) ng/mL 20.2 (7.51) ng/mL
Alzohily et al. (22) Randomized, double-blind, placebo-controlled trial 3 baseline (vitamin D deficient obese), follow-up (supplemented obese), and healthy volunteers Age range of healthy males (18–29), and females (18–65) Not mentioned Healthy volunteers- Males (n = 8); Females (n = 167) Emirati citizens and Middle Eastern expatriates N = 452 Baseline and Follow-up (n = 277); Healthy volunteers (n = 175) Healthy volunteers 25OH vitamin D3: 12.56 ± 3.84 ng/ml Conversion not needed

VTD, Vitamin D; T2D, Type 2 diabetes.

Table 2.

Summary of studies reporting vitamin D levels in individuals below 18 years of age.

Author name Study design Number of arms(groups) Study population age range Study population mean SD (Age) Study population gender Study population ethnicity Sample size Sample per arm Reported value Converted value (ng/mL) SD
Rajah et al. (15) Prospective study 4 (0–0.9 y, 1–1.9 y, 2–7.9 y, 8–14 y) < 14 y 5.32 (3.76) Males (n = 88); Females (n = 81) Not mentioned N = 169 0–0.9 y (n = 16); 1–1.9 y (n = 26); 2–7.9 y (n = 79); 8–14 (n = 48) 53.6 (33.4) nmol/L 21.5 (13.4) ng/mL 13.4ng/mL
Muhairi et al. (13) Cross-sectional study 1 12 to 18 years Mean age (SD) was 16 years for females (0.6) as well as for males (0.9) Male (n = 150); Female (n = 165) Emirati, and others (Arab, and Gulf countries). N = 315 Nil Mean serum 25 (OH) D concentrations in Emirati females: 20.8 ng/mL (95% CI 18.8–22.8), Emirati males: (mean 25.2 ng/mL; 95% CI 23.7–26.8), non- Emirati females: 21.9 ng/mL (95% CI; 19.8–23.9), non- Emirati males (mean 28.3; 95% CI 24.6–31.9). Conversion not needed Not mentioned
Narchi et al. (14) Cross-sectional Analytical study 1 11–18 years 15.2 (2.0) Females Emirati N = 293 Nil 21.5 (10.0) nmol/L. 8.6 (4) ng/mL 4 ng/mL
Majeed et al. (12) Case control study 2 (T1D cases and NG controls) Not mentioned NG controls—11.9 (10.1, 14.6) NG controls—Female (n = 173); Male (n = 123) Emirati N = 444 T1D cases (n = 148); NG controls (n = 296) NG controls -Median (IQR): 34.9 (23.6, 50.5) (nmol/L) NG controls - median (IQR): 14 (9.5, 20.2) ng/mL Not mentioned

T1D, Type 1 Diabetes; NG, normoglycemic.

Table 3.

Summary of studies reporting vitamin D levels among mothers and their infants.

Author name Study design Number of arms(groups) Study population age range Study population mean SD (Age) Study population gender Study population ethnicity Sample size Sample per arm Reported value Converted value (ng/mL) SD
Dawodu et al. (38) Not mentioned 2 (mothers and (infants and young children)) Infants and young children: 5–35 months Infants and young children mean: 15.4 months Infants and young children: (Male / Female): 31/20 Infants and children: Emirati (n = 26); non-Gulf Arabs (n = 25) N = 101 Infants and young children (n = 50) Infants and children: 49.8 (30.8) nmol/L Infants and children: 20 (12.3)ng/mL Infants and children: 12.3ng/mL
Mother: not mentioned Mothers: not mentioned Mothers: females Mothers: not mentioned Mothers (n = 51) Mothers: 28.4 (14.0) nmol/L Mothers: 11.4 (5.6)ng/mL Mothers: 5.6 ng/mL
Dawodu et al. (39) Not mentioned 2 (mothers and infants) Infants: 4 to 16 weeks Median age of infants: 6 weeks Infants: not mentioned Infants: Arab and South Asian N = 168 Infants (n = 78) Infant median (quartiles): 4.6 (2.5, 7.9)ng/mL Conversion not needed Not mentioned
Mothers not mentioned Mean age of the mothers was 27.1 ± 6.0 years. Mothers: female Mothers not mentioned Mothers (n = 90) Mothers median (quartiles): 8.7 (5.9, 13.6)ng/mL Conversion not needed Not mentioned
Saadi, et al. (44) Not mentioned 3 (breastfeeding women receiving daily regimen, breastfeeding women receiving monthly regimen, and infants receiving daily regimen) Not mentioned Infants of mothers*receiving daily regimen (N = 45) 18.9 ± 22.5 *receiving monthly regimen (N = 47) 22.4 ± 25.6 Infants: not mentioned Infants not mentioned N = 182 Infants (n = 92) Infants of mothers *receiving daily regimen (N = 45) 13.1 ± 7.1 nmol/L
*receiving monthly regimen (N = 47) 15.0 ± 10.9 nmol/L
Infants of mothers *receiving Daily regimen (N = 45) 5.2 ± 2.8 ng/mL
*receiving Monthly regimen (N = 47) 6 ± 4.4 ng/mL
Infants of mothers*receiving Daily regimen (N = 45) SD: 2.8 ng/mL *receiving Monthly regimen (N = 47) SD: 4.4 ng/mL
Mothers *receiving daily regimen: 29.2 ± 5.5;
*receiving monthly regimen 29.9 ± 6.7
Mothers: Female Mothers: Arabs (n = 76) and South Asians (n = 14) Healthy breastfeeding mothers (n = 90)
*Receiving daily regimen (N = 45)
*Receiving monthly regimen (N = 45)
Mothers *receiving daily regimen: 27.3 ± 10.4 nmol/L;
* receiving monthly regimen 23.2 ± 10.7 nmol/L
Mothers *receiving daily regimen: 10.9 ± 4.2 ng/mL
*receiving monthly regimen 9.3 ± 4.3 ng/mL
Mothers *receiving Daily regimen (N = 45) SD: 4.2 ng/mL *receiving monthly regimen (N = 45) SD: 4.3 ng/mL
Amirlak et al. (37) Convenience sample, Pilot study 2 (mothers and infants) Not mentioned Infants: not mentioned Infants: not mentioned Infants: not mentioned N = 168 Infants (n = 84) Infants cord blood median (IQR): 9.9 (7.6, 17.4) nmol/L Infants cord blood median (IQR): 4 (3, 7) ng/mL Not mentioned
Median (IQR) age of the women was 27 (23; 31) Mothers: Females Mothers: Arab (n = 68), and South-East Asian (n = 16) (Indian and Pakistani) Mothers (n = 84) Maternal median (IQR): 18.5 (11.0, 25.4) nmol/L Maternal median (IQR): 7.4 (4.4, 10.2) ng/mL Not mentioned
Narchi, et al. (43) Prospective longitudinal cohort study 1 18–40 years Median age: 27 years Females Egyptian (n = 20), Palestinian (n = 16), Joardanian (n = 13) Sudanese (n = 8), others (n = 18) N = 75 Nil 17.3 (10.5) ng/mL Conversion not needed 10.5 ng/mL
Narchi, et al. (42) Prospective, longitudinal cohort study 2 (mothers and infants) Not mentioned Infant median (range) * at birth: 3 days (2–7); * After 6 months: 4 weeks (12–32) Infants: Males (n = 16), Females (n = 11) Infants: not mentioned N = 50 Infants (n = 27) Infants mean (SD) *At birth: 44.7 (29.7)nmol/L; *After 6 months: 106 (48.7)nmol/L Infants mean (SD) *At birth: 17.9 (11.9)ng/mL; *After 6 months: 42.5 (19.5)ng/mL Infants (SD) *At birth: (11.9)ng/mL; *After 6 months: (19.5)ng/mL
Mothers: not mentioned Mothers: Females Mothers: Middle Eastern and Asian origin Mothers (n = 23) Mothers mean (SD): 35.5 (24.7)nmol/L Mothers mean (SD): 14.2 (9.9) ng/mL Mothers SD: 9.9 ng/mL
Dawodu and Nath et al. (40) Not mentioned 1 Not mentioned Mean (SD): 27.0 (5.5) years Females Arab N = 28 Nil Maternal Median (IQR): 17.0 (12.0, 21.5) nmol/L 6.8 (4.8, 8.6) ng/mL Not mentioned
Jutell, et al. (41) Prospective observational study 3 (Group I: 25(OH)D < 25 nmol/L, Group II: 25(OH)D 25 nmol/L to < 50 nmol/L, Group III: 25(OH)D > 50 nmol/L) Not mentioned Group I: 29.8 ± 6.25, Females Middle east, Africa, Southeast Asia N = 286 Group I (n = 64) Group I: 17.5 ± 4.9 nmol/L Group I: 7 ± 1.96 ng/mL 1.96 ng/mL
Group II: 30.2 ± 5.24 Group II (n = 72) Group II: 37.3 ± 7.55 nmol/L Group II: 14.92 ± 3.0 ng/mL 3 ng/mL
Group III: 30.9 ± 6.22 Group III (n = 150) Group III: 81.7 ± 23.73 nmol/L Group III: 32.68 ± 9.5 ng/mL 9.5 ng/mL

The Vitamin D levels reported across all 35 included studies ranged from 5.2 ± 2.8 ng/mL to 42.5 ± 19.5 ng/mL. Among children under 18 years of age, the lowest reported level was 8.6 ± 4 ng/mL, while the highest was 21.5 ± 13.4 ng/mL (12–15). For individuals over 18 years, the lowest level reported was 6.3 ± 2.78 ng/mL, and the highest was 31.20 ± 21.4 ng/mL (7, 8, 16–36).

Out of the total 28,260 subjects, 18,451 were female, 9,478 were male and 331 were infants whose gender was not specified. Male participants were 65%, females 34, and 1% infants.

Among 35 studies, we included 8 studies about moms and infants, however only 5 out of 8 studies met our inclusion criteria for infants (37–44). In addition, 8 studies included only female participants. The remaining 19 studies included both male and female participants. In this present systematic review, 11 studies were done on Emirati participants, among which 9 studies were conducted in above 18, 2 studies in under 18, and none in the mom and infants group.

The age range of participants widely varied across the included articles. Most of the studies focused on adults aged 18 years and above with some studies reporting age ranges. A few studies included broader age ranges such as 18–106 years, 20–85 years, and 20–75 years. There are studies specifying subgroups for example the participants within the fertile age range of 19–44 years (Supplementary Table 1).

The average quality analysis score of studies as done by the modified Newcastle Ottawa scale is 2.65 (Figure 2). The mean score of quality analysis calculated for each group is as follows, 2.82 (above 18), 2.0 (mom and infants), and 3.0 (under 18; Supplementary Table 2).

Figure 2.

Bar chart displaying different studies with color-coded bars indicating the presence of various methodological elements. Categories include definition of controls, reported value, quality assurance of lab method, ethics committee, and sample size calculations. Each study is represented by a horizontal line with corresponding colors to show which elements are present. The studies are listed on the vertical axis, and the horizontal axis is numbered from zero to five.

Quality assessment using the modified version of the Newcastle–Ottawa scale.

A meta-analysis of 17 studies was conducted using a random-effects model to estimate the pooled mean and explore sources of heterogeneity. The overall pooled mean was 17.63 (95% CI: 14.28 to 20.99), with very high heterogeneity observed (I2 = 99.71%, τ2 = 49.42, p < 0.0001; Figure 3). Metaregression moderator analysis indicated that the measurement method was a significant source of variation (QM = 14.84, p = 0.0381), with studies using combined methods, HPLC, and RIA reporting significantly lower mean values compared to the reference method. In contrast, sample size (p = 0.4795) and study location (p = 0.4724) were not significant moderators when examined independently. The full mixed-effects model, which included sample size, location, and method, explained approximately 43.8% of the heterogeneity (QM = 21.29, p = 0.0114), with the measurement method remaining a significant predictor. Sample size and location showed marginal or borderline effects in the full model, suggesting that measurement technique was the primary contributor to the observed between-study variability.

Figure 3.

Forest plot displaying various studies on the left with corresponding estimate values and confidence intervals on the right. Each study is represented by a square and horizontal line indicating the confidence interval. A diamond at the bottom represents the random-effects model estimate. Studies are listed chronologically from 2004 to 2024.

Forest plot of pooled vitamin D levels among studies. The model was estimated using the random effects model using R package version 4.4.2.

In adults above 18 years of age included in the meta-analysis, 5 out of 17 studies stated vitamin D deficiency as levels below 20 ng/mL, however, one study mentioned <20 ng/mL as insufficiency (21–23, 28, 35). Six studies included participants who were exclusively Emirati (16, 17, 21, 32, 30, 36). Thirteen studies assessed the correlation between Body Mass Index (BMI) and vitamin D level (16, 17, 20–23, 28–31, 33–35), of which only 5 found a statistically significant correlation (16, 23, 31, 34, 35).

Out of the 23 studies assessed in the above 18 years category, 17 were included in the meta-analysis, while 6 were excluded due to data limitations. Al Zarooni et al. (7), Bani-Issa et al. (25), and Al Zarooni et al. (18), Dawodu et al. (26) were excluded as they only provided categorical data. Dawodu et al. (27) was excluded due to a small sample size (n = 8), reducing its statistical reliability. We excluded Anouti et al. (24) from meta-analysis as it did not report results for the entire study population, and 13.52 ± 6.86 ng/mL was derived and not presented in the study (45).

In our systematic review, the most commonly used study design was the cross-sectional study, followed by prospective studies, randomized controlled trials, case–control studies, and pilot studies. Additionally, there were 9 articles, where the study design was not mentioned. All the studies were conducted with venous blood collected samples and none were with saliva.

Out of all the studies, Radioimmunoassay (RIA) was mostly used to measure the Vitamin D levels—9 times, followed by Electrochemiluminescence immunoassay, used 6 times. Other studies utilize chemiluminescence immunoassay, Immunoassay, Beckman Coulter analyzers, and a combination of methods for vitamin D assay. Whereas 4 studies did not mention the specific assay technique used. This variation in assay methods highlights the difference in measurement approaches across the included studies.

Among the 35 studies included in the systematic review, 21 utilized questionnaires as their primary assessment tool. Three studies assessed for depression; one used the Patient Health Questionnaire (PHQ-9), and 2 employed the Beck Depression Inventory (BDI). The remaining studies used a questionnaire focused on lifestyle factors, including average duration of sunlight exposure, dietary history, and dress style.

Discussion

Our study revealed that the pooled mean (SD) obtained from studies reporting vitamin D levels is in the range of vitamin D deficiency. The studies included in the systematic review consisted of 35 studies (8–mom and infants, 4–under 18, 23–above 18; Tables 13) involving 28,260 subjects (N = 1,058—mom and infants, N = 1,073—under 18, N = 26,129—above 18).

The findings of meta-analysis highlight the substantial heterogeneity across studies, as indicated by the high I (2) value of 99.71%, suggesting that differences in study characteristics significantly influenced the reported outcomes (Figure 3). Among the examined moderators, the method of measurement emerged as a key source of heterogeneity. Studies employing combined methods, HPLC, and RIA consistently reported lower mean values compared to the reference method, underscoring the impact of analytical techniques on study results. In contrast, neither sample size nor study location significantly accounted for the observed variability when considered independently. However, when included in a mixed-effects model, the combination of moderators explained nearly 44% of the total heterogeneity, with the measurement method remaining a significant predictor. These results emphasize the need for standardization in measurement approaches across studies to improve comparability and reduce methodological bias in future research.

Overall our included studies from 1998 to 2024 have reported that vitamin D deficiency is significant in our population. This is in concurrence with another systematic review done in India (46). However, there is another systematic review of vitamin D status in populations worldwide which showed vitamin D levels in the normal range in certain countries (2).

The total studies included in the under 18 category are 4 with total subjects of 1,073. This also indicates that the data reporting on vitamin D levels among children and adolescents are sparse compared to adults.

In the same line, only 8 studies have reported vitamin D levels among mothers and infants. The vitamin D levels among mothers ranged from 7 ± 1.96 ng/mL to 32.68 ± 9.5 ng/mL (41) and among infants the range was from 5.2 ± 2.8 ng/mL to 42.5 ± 19.5 ng/mL (39, 42). The recommended normal vitamin D level for pregnant women and infants, as stated by the World Health Organization (WHO), is above 50 nmol/L (20 ng/mL) (47, 48).

Vitamin D deficiency is highly prevalent among both pregnant women and adolescents, but the priority and approach to intervention should differ: pregnant women require more urgent and higher-dose supplementation because deficiency is linked to serious maternal and neonatal complications such as preeclampsia, gestational diabetes, preterm birth, and low birth weight. Thus, interventions for pregnant women should be prioritized and integrated into prenatal care with routine monitoring (49, 50).

While adolescents though also at risk for deficiency-related bone and growth problems generally benefit from intermediate-dose supplementation and targeted screening mainly if risk factors are present. For adolescents, a population-level approach with supplementation and lifestyle advice is usually sufficient unless additional risks are identified (49, 51).

UAE is known for its desert climate and abundant sunshine throughout the year. Despite this, vitamin D deficiency remains a significant health problem. Factors contributing to this paradox include cultural clothing practices that decrease skin surface area exposed to sunlight, extremely hot weather that discourages outdoor activities, dark skin tones that reduce vitamin D synthesis, and insufficient intake of vitamin D-rich foods (18).

Out of the 35 studies reviewed, only three explicitly referenced the seasons during which data were collected. These included the study by Fatme Al Anouti et al. (17), conducted during both winter and summer; the study by Justin Thomas et al. (36), conducted in the fall; and the study by Adekunle Dawodu et al. (39), conducted in the summer. In contrast, 22 studies reported only a range of months without specifying the corresponding seasons, while the remaining studies did not mention the timing of data collection at all.

One study has reported seasonal variation in vitamin D levels between summer and winter. During the summer, vitamin D levels were lower, with females having an average of 8.4 ± 6 ng/mL and males 10.9 ± 6.3 ng/mL. In contrast, winter levels were higher, with females averaging 12.5 ± 4.9 ng/mL. The difference between summer and winter was statistically significant, suggesting that seasonal variations play a major role in vitamin D status. This variation is likely due to factors such as sunlight exposure, as intense summer heat may discourage outdoor activity, while cooler winter weather encourages more time outside, leading to greater vitamin D production (17).

A study reported that participants engaging in daily physical activity had the highest mean vitamin D levels (15.28 ng/mL), while those with minimal activity exhibited the lowest levels (12.68 ng/mL). Work nature also influenced vitamin D status, with individuals spending most of their time sitting at work showing the lowest mean levels (11.84 ng/mL). Whereas, participants whose jobs required physical exertion had higher mean levels (14.84 ng/mL) (18).

Similarly, cultural practices particularly clothing styles that limit skin exposure are major contributors. One study reported that 51% of mothers and 22% of children had serum 25-hydroxyvitamin D (25-OHD) levels below 10 ng/mL. Limited sun exposure (mean 38 min/day) and heavy clothing, with 95% of children exposing only their face and hands outdoors, were identified as key risk factors (38). Nimri et al. showed that the prevalence of low vitamin D levels varies significantly between individuals wearing hijabs and those adopting a Western dress style. Among individuals wearing hijab, 37.5% were found to have low vitamin D levels. In contrast, those following a Western dress style had a lower prevalence, with only 16.7% reporting low vitamin D levels (31). Another study highlighted that Emirati women of childbearing age had a mean serum 25-OHD level of 8.6 ng/mL, far below the 64.3 ng/mL observed in Europeans living in the UAE. This discrepancy correlated strongly with clothing styles that covered most of the body, reducing effective UVB exposure (26).

The factors for prevalent vitamin D deficiency are well-reviewed in multiple studies. Among them, the causes for the UAE context are limited sunlight exposure, urban areas, or those following indoor lifestyles (20). Cultural or religious practices requiring full-body coverings and darker skin pigmentation, which reduces the skin’s ability to synthesize vitamin D, also contribute significantly (26, 31, 38). Seasonal variations, particularly in summer, further exacerbate the vitamin D deficiency (17). Obesity, aging, and medications that interfere with vitamin D metabolism also increase vulnerability, as do exclusive breastfeeding without supplementation for infants (21, 44).

Strengths

This systematic review, conducted in accordance with the 2020 PRISMA guidelines, is the first to report on vitamin D levels in the UAE. Data were collected from inception to date using two large databases. Articles were systematically categorized into three demographic groups: mothers and infants, under 18 years of age, and above 18 years of age. We accounted for variations in reference levels used to categorize deficiency, insufficiency, and normal vitamin D status across all articles, which offer a clear comparison and comprehensive interpretation of vitamin D status across different groups. Also, we assessed all our articles based on the modified version of the Newcastle–Ottawa scale, for quality assessment, scoring them between 0 to 5 (Figure 2).

Limitations

We did not segregate the data based on the seasons, which could have influenced Vitamin D levels due to variations in sunlight exposure across the year. Individuals in the UAE may have greater exposure to sunlight during winter months which leads to higher vitamin D levels compared to the summer months. The study population in the UAE is heterogeneous and multi-ethnic, which may introduce variability that was not fully accounted for in the analysis.

One more significant limitation of this systematic review is the lack of information regarding the duration of stay of migrant participants in the UAE. This missing data could influence the interpretation of findings, as the length of stay may affect participants’ vitamin D values.

The scope of our research was limited, as key databases such as Embase, Web of Science, and Google Scholar were not included. We recommend that future systematic reviews incorporate these databases to enhance the comprehensiveness of the search.

Future direction

Future research should explore vitamin D levels in the Emirati population to gain a deeper understanding of local trends, taking into account unique factors such as genetics, dietary habits, and cultural practices.

Additionally, studies examining seasonal variations in vitamin D levels considering the differences in sunlight exposure between summer and winter months, would provide valuable insights into the impact of seasonal changes on health. Conducting a longitudinal study to track the changes in vitamin D over time.

Moreover, studies with larger sample sizes should be prioritized to enhance the reliability and generalizability of findings. A more extensive sample would allow for greater statistical power and more robust subgroup analyses, enabling a better understanding of variations in vitamin D levels across diverse populations.

While cross-sectional and retrospective studies are effective for estimating prevalence, they limit causal inference. We recommend that future studies in the UAE employ long-term longitudinal or interventional designs to assess causality between lifestyle factors and vitamin D status. Further, future studies should underscore the need for targeted public health strategies, which should be explored in dedicated intervention studies.

In addition, there is a need to conduct systematic reviews specifically focused on the Emirati population. In our current systematic review, only 11 articles included exclusively Emirati participants. Targeting this population in future studies would provide more representative data and contribute to a better understanding of vitamin D status in the UAE.

Conclusion

Vitamin D deficiency is a significant public health concern in the UAE, even among the apparently healthy population. This systematic review reveals that vitamin D deficiency is prevalent across various demographic groups, including different age ranges including mothers and infants, children (below 18 years) and adults (above 18 years), genders, and socio-economic states. The Vitamin D levels reported across all 35 included studies ranged from 5.2 ± 2.8 ng/mL to 42.5 ± 19.5 ng/mL. The pooled mean (SD) of vitamin D for adults above 18 years was 17.63 (CI 14.28 to 20.99). According to our analysis of the articles included in this systematic review, we found that infants had the lowest vitamin D levels.

Furthermore, differences in assay techniques across studies—such as radioimmunoassay (RIA), electrochemiluminescence immunoassay (ECLIA), and LC–MS/MS—can significantly impact measured vitamin D values and should be carefully considered when interpreting results or formulating public health guidelines.

Acknowledgments

The authors sincerely thank the RAKMHSU administration for their valuable support. They also gratefully acknowledge U. S. Chakradhara Rao, Research Platform for Pediatric Onco-Hematology, University of Geneva, Switzerland, for his generous support in the data analysis.

Funding Statement

The author(s) declare that no financial support was received for the research and/or publication of this article.

Data availability statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Author contributions

MA: Data curation, Investigation, Methodology, Resources, Validation, Visualization, Writing – original draft, Writing – review & editing. WF: Data curation, Investigation, Methodology, Resources, Validation, Visualization, Writing – original draft. MTA: Data curation, Investigation, Methodology, Resources, Visualization, Writing – original draft. SS: Conceptualization, Project administration, Resources, Software, Supervision, Validation, Writing – review & editing.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Gen AI was used in the creation of this manuscript.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2025.1604819/full#supplementary-material

Data_Sheet_1.pdf (255.8KB, pdf)

References

  • 1.Siddiqee MH, Bhattacharjee B, Siddiqi UR, MeshbahurRahman M. High prevalence of vitamin D deficiency among the south Asian adults: a systematic review and meta-analysis. BMC Public Health. (2021) 21:1823. doi: 10.1186/s12889-021-11888-1, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, et al. A systematic review of vitamin D status in populations worldwide. Br J Nutr. (2014) 111:23–45. doi: 10.1017/S0007114513001840, PMID: [DOI] [PubMed] [Google Scholar]
  • 3.Dwivedi S, Singh V, Sen A. Vitamin D in disease prevention and cure – part I: an update on molecular mechanism and significance on human health. Indian J Clin Biochem. (2024). doi: 10.1007/s12291-024-01251-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zhang Y, Fang F, Tang J, Jia L, Feng Y, Xu P, et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. (2019) 366:l4673. doi: 10.1136/bmj.l4673, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Borel P, Caillaud D, Cano NJ. Vitamin D bioavailability: state of the art. Crit Rev Food Sci Nutr. (2015) 55:1193–205. doi: 10.1080/10408398.2012.688897, PMID: [DOI] [PubMed] [Google Scholar]
  • 6.Chakhtoura M, Rahme M, Chamoun N, El-Hajj Fuleihan G. Vitamin D in the Middle East and North Africa. Bone Reports. (2018) 8:135–46. doi: 10.1016/j.bonr.2018.03.004, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Al Zarooni AAR, Al Marzouqi FI, Al Darmaki SH, Prinsloo EAM, Nagelkerke N. Prevalence of vitamin D deficiency and associated comorbidities among Abu Dhabi emirates population. BMC Res Notes. (2019) 12:503. doi: 10.1186/s13104-019-4536-1, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Yammine K, Al Adham H. The status of serum vitamin D in the population of the United Arab Emirates. East Mediterr Health J. (2016) 22:682–6. doi: 10.26719/2016.22.9.682, PMID: [DOI] [PubMed] [Google Scholar]
  • 9.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wells GA, Shea BJ, O’Connell D, Peterson j, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [abstract]—Cochrane methodology register. (2014). Available online at: https://cmr.cochrane.org/?CRGReportID=2972 (Accessed on February 14, 2025).
  • 11.Abbas A, Hefnawy MT, Negida A. Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis. BMC Med Res Methodol. (2024) 24:243. doi: 10.1186/s12874-024-02356-6, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Majeed M, Siddiqui M, Lessan N. Vitamin D deficiency increases with age and adiposity in Emirati children and adolescents irrespective of type 1 diabetes mellitus: a case control study. BMC Endocr Disord. (2023) 23:150. doi: 10.1186/s12902-023-01405-3, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Muhairi SJ, Mehairi AE, Khouri AA, Naqbi MM, Maskari FA, Kaabi JA, et al. Vitamin D deficiency among healthy adolescents in Al Ain, United Arab Emirates. BMC Public Health. (2013) 13:33. doi: 10.1186/1471-2458-13-33 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Narchi H, Kochiyil J, Al Hamad S, Yasin J, Laleye L, Al Dhaheri A. Hypovitaminosis D in adolescent females—an analytical cohort study in the United Arab Emirates. Paediatr Int Child Health. (2015) 35:36–43. doi: 10.1179/2046905514Y.0000000144, PMID: [DOI] [PubMed] [Google Scholar]
  • 15.Rajah J, Haq A, Pettifor JM. Vitamin D and calcium status in urban children attending an ambulatory clinic service in the United Arab Emirates. Dermatoendocrinol. (2012) 4:39–43. doi: 10.4161/derm.18250, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Abdulle A, Inman CK, Saleh A, Noshi M, Galani D, Abdelwareth L, et al. Metabolic dysfunction in Emirati subjects in Abu Dhabi: relationship to levels of soluble RAGEs. J Clin Transl Endocrinol. (2019) 16:100192. doi: 10.1016/j.jcte.2019.100192, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Al Anouti F, Thomas J, Abdel-Wareth L, Rajah J, Grant WB, Haq A. Vitamin D deficiency and sun avoidance among university students at Abu Dhabi, United Arab Emirates. Dermatoendocrinol. (2011) 3:235–9. doi: 10.4161/derm.3.4.16881, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Al Zarooni AAR, Nagelkerke N, Al Marzouqi FI, Al Darmaki SH. Risk factors for vitamin D deficiency in Abu Dhabi Emirati population. PLoS One. (2022) 17:e0264064. doi: 10.1371/journal.pone.0264064, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Al-Amad SH, Hasan H. Vitamin D and hematinic deficiencies in patients with recurrent aphthous stomatitis. Clin Oral Investig. (2020) 24:2427–32. doi: 10.1007/s00784-019-03102-9, PMID: [DOI] [PubMed] [Google Scholar]
  • 20.Al-Anouti F, Al-Ameri S, Thomas J, Abdel-Wareth L, Devkaran S, Rajah J, et al. Sun avoidance among indoor employees leading to vitamin D deficiency and depression in the United Arab Emirates. Int J Med Med Sci. (2013) 5:503–9. doi: 10.5897/IJMMS2013.0963 [DOI] [Google Scholar]
  • 21.AlAnouti F, Ahmad AS, Wareth LA, Dhaheri AA, Oulhaj A, Junaibi AA, et al. Associations between serum 25-hydroxyvitamin D, body mass index and body fat composition among Emirati population: results from the UAE healthy future study. Front Endocrinol. (2022) 13:954300. doi: 10.3389/fendo.2022.954300, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Alzohily B, AlMenhali A, Gariballa S, Munawar N, Yasin J, Shah I. Unraveling the complex interplay between obesity and vitamin D metabolism. Sci Rep. (2024) 14:7583. doi: 10.1038/s41598-024-58154-z, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Anouti FA, Ahmed LA, Riaz A, Grant WB, Shah N, Ali R, et al. Vitamin D deficiency and its associated factors among female migrants in the United Arab Emirates. Nutrients. (2022) 14:1074. doi: 10.3390/nu14051074, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Anouti FA, Chehadeh SEH, Osman E, ElGhazali G, Safar HA. Investigating the association of vitamin D metabolism genes CYP2R1, CYP24A1 and CYP27B1 with vitamin D status in young adult Emiratis. J Food Nutr Res. (2017) 5:15–21. doi: 10.12691/jfnr-5-1-3 [DOI] [Google Scholar]
  • 25.Bani-Issa W, Eldeirawi K, Harfil S, Fakhry R. Vitamin D deficiency and its determinants in adults: a sample from community-based settings in the United Arab Emirates. Int J Endocrinol. (2017) 2017:1–7. doi: 10.1155/2017/3906306, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Dawodu A, Absood G, Patel M, Agarwal M, Ezimokhai M, Abdulrazzaq Y, et al. Biosocial factors affecting vitamin D status of women of childbearing age in the United Arab Emirates. J Biosoc Sci. (1998) 30:431–7. doi: 10.1017/s0021932098004313, PMID: [DOI] [PubMed] [Google Scholar]
  • 27.Dawodu A, Kochiyil J, Altaye N. Pilot study of sunlight exposure and vitamin D status in Arab women of childbearing age. Eastern Mediterranean Health J = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit. (2011) 17:570–4. [PubMed] [Google Scholar]
  • 28.Gariballa S, Shah I, Yasin J, Alessa A. Vitamin D [25(OH)D] metabolites and epimers in obese subject: interaction and correlations with adverse metabolic health risk factors. J Steroid Biochem Mol Biol. (2022) 215:106023. doi: 10.1016/j.jsbmb.2021.106023, PMID: [DOI] [PubMed] [Google Scholar]
  • 29.Hasan HA, AbuOdeh RO, Muda WAMBW, Mohamed HJBJ, Samsudin AR. Association of vitamin D receptor gene polymorphisms with metabolic syndrome and its components among adult Arabs from the United Arab Emirates. Diabetes Metab Syndr Clin Res Rev. (2017) 11:S531–7. doi: 10.1016/j.dsx.2017.03.047 [DOI] [PubMed] [Google Scholar]
  • 30.Inman CK, Aljunaibi A, Koh H, Abdulle A, Ali R, Alnaeemi A, et al. The AGE-RAGE axis in an Arab population: the United Arab Emirates healthy futures (UAEHFS) pilot study. J Clin Transl Endocrinol. (2017) 10:1–8. doi: 10.1016/j.jcte.2017.08.001, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Nimri LF. Vitamin D status of female UAE college students and associated risk factors. J Public Health (Oxf). (2018) 40:e284–90. doi: 10.1093/pubmed/fdy009, PMID: [DOI] [PubMed] [Google Scholar]
  • 32.Saadi HF, Reed RL, Carter AO, Al-Suhaili AR. Correlation of quantitative ultrasound parameters of the calcaneus with bone density of the spine and hip in women with prevalent hypovitaminosis D. J Clin Densitom. (2004) 7:313–8. doi: 10.1385/jcd:7:3:313, PMID: [DOI] [PubMed] [Google Scholar]
  • 33.Saadi HF, Nagelkerke N, Benedict S, Qazaq HS, Zilahi E, Mohamadiyeh MK, et al. Predictors and relationships of serum 25 hydroxyvitamin D concentration with bone turnover markers, bone mineral density, and vitamin D receptor genotype in Emirati women. Bone. (2006) 39:1136–43. doi: 10.1016/j.bone.2006.05.010, PMID: [DOI] [PubMed] [Google Scholar]
  • 34.Saeed BQ, Jairoun AA, Ashraf Khamis A, Hatim Abdelrahim L, Abobakr Aljomhi A, Adrees AO, et al. Vitamin D deficiency and insufficiency among university students: prevalence, risk factors, and the association between vitamin D deficiency and episodes of respiratory tract infections. Risk Manag Healthc Policy. (2021) 14:2733–41. doi: 10.2147/RMHP.S308754, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Saheb Sharif-Askari F, Saheb Sharif-Askari N, Halwani R, Abusnana S, Hamoudi R, Sulaiman N. Low vitamin D serum level is associated with HDL-C dyslipidemia and increased serum Thrombomodulin levels of insulin-resistant individuals. Diabetes, Metabolic Syndrome Obesity: Targets Therapy. (2020) 13:1599–607. doi: 10.2147/DMSO.S245742, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Thomas J, Al-Anouti F. Sun exposure and behavioral activation for Hypovitaminosis D and depression: a controlled pilot study. Community Ment Health J. (2018) 54:860–5. doi: 10.1007/s10597-017-0209-5, PMID: [DOI] [PubMed] [Google Scholar]
  • 37.Amirlak I, Ezimokhai M, Dawodu A, Dawson KP, Kochiyil J, Thomas L, et al. Current maternal-infant micronutrient status and the effects on birth weight in the United Arab Emirates. Eastern Mediterranean Health J = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit. (2009) 15:1399–406. [PubMed] [Google Scholar]
  • 38.Dawodu A, Dawson KP, Amirlak I, Kochiyil J, Agarwal M, Badrinath P. Diet, clothing, sunshine exposure and micronutrient status of Arab infants and young children. Ann Trop Paediatr. (2001) 21:39–44. doi: 10.1080/02724930124951, PMID: [DOI] [PubMed] [Google Scholar]
  • 39.Dawodu A, Agarwal M, Hossain M, Kochiyil J, Zayed R. Hypovitaminosis D and vitamin D deficiency in exclusively breast-feeding infants and their mothers in summer: a justification for vitamin D supplementation of breast-feeding infants. J Pediatr. (2003) 142:169–73. doi: 10.1067/mpd.2003.63, PMID: [DOI] [PubMed] [Google Scholar]
  • 40.Dawodu A, Nath R. High prevalence of moderately severe vitamin D deficiency in preterm infants. Pediatr Int. (2011) 53:207–10. doi: 10.1111/j.1442-200X.2010.03209.x, PMID: [DOI] [PubMed] [Google Scholar]
  • 41.Jutell M, Bhat S, Bagge ML, Isberg P-E, Wiberg N. Correlation between maternal and umbilical cord 25-hydroxy-vitamin D levels over a range of values. A prospective observational study from the United Arab Emirates. PLoS One. (2024) 19:e0299862. doi: 10.1371/journal.pone.0299862, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Narchi H, Kochiyil J, Zayed R, Abdulrazzak W, Agarwal M. Longitudinal study of vitamin D status in the 1st 6 months of life. Ann Trop Paediatr. (2011) 31:225–30. doi: 10.1179/1465328111Y.0000000017, PMID: [DOI] [PubMed] [Google Scholar]
  • 43.Narchi H, Kochiyil J, Zayed R, Abdulrazzak W, Agarwal M. Maternal vitamin D status throughout and after pregnancy. J Obstetrics Gynaecol: J Institute Obstetrics Gynaecol. (2010) 30:137–42. doi: 10.3109/01443610903315652, PMID: [DOI] [PubMed] [Google Scholar]
  • 44.Saadi HF, Dawodu A, Afandi B, Zayed R, Benedict S, Nagelkerke N, et al. Effect of combined maternal and infant vitamin D supplementation on vitamin D status of exclusively breastfed infants. Matern Child Nutr. (2009) 5:25–32. doi: 10.1111/j.1740-8709.2008.00145.x, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.CombineMeanSD . (2020). Available online at: https://www.statstodo.com/CombineMeansSDs.php (Accessed on March 15, 2025)
  • 46.Selvarajan S, Gunaseelan V, Anandabaskar N, Xavier A, Srinivasamurthy S, Kamalanathan S, et al. Systematic review on vitamin D level in apparently healthy Indian population and analysis of its associated factors. Indian J Endocrinol Metabolism. (2017) 21:765–75. doi: 10.4103/ijem.IJEM_168_17, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.World Health Organization (2012). Guideline: vitamin D supplementation in pregnant women. Available online at: https://iris.who.int/bitstream/handle/10665/85313/9789241504935_eng.pdf;jsessionid=96F37C8A54D9C9F8E629C4398473EB47?sequence=1 (Accessed February 02, 2025).
  • 48.Weiler HA. Vitamin D Supplementation for Infants. (2017). Available online at: https://www.who.int/tools/elena/bbc/vitamind-infants (Accessed on February 2, 2025).
  • 49.Płudowski P, Kos-Kudła B, Walczak M, Fal A, Zozulińska-Ziółkiewicz D, Sieroszewski P, et al. Guidelines for preventing and treating vitamin D deficiency: a 2023 update in Poland. Nutrients. (2023) 15:695. doi: 10.3390/nu15030695, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. (2011) 96:1911–30. doi: 10.1210/jc.2011-0385, PMID: [DOI] [PubMed] [Google Scholar]
  • 51.Chakhtoura M, El Ghandour S, Shawwa K, Akl E, Arabi A, Mahfoud Z, et al. Vitamin D replacement in children, adolescents and pregnant women in the Middle East and North Africa. Metab Clin Exp. (2017) 70:160–76. doi: 10.1016/j.metabol.2017.02.009 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data_Sheet_1.pdf (255.8KB, pdf)

Data Availability Statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.


Articles from Frontiers in Nutrition are provided here courtesy of Frontiers Media SA

RESOURCES